{"id":"https://openalex.org/W7096949619","doi":null,"title":"ORIGINAL RESEARCH ARTICLE Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","display_name":"ORIGINAL RESEARCH ARTICLE Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","publication_year":2015,"publication_date":"2015-03-12","ids":{"openalex":"https://openalex.org/W7096949619"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.571.8592","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.571.8592","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.chrisparsons.de/Chris/Acrobat/Eisensamer_2003.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"B Eisensamer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Eisensamer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G Rammes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Rammes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G Gimpl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Gimpl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083482494","display_name":"M Shapa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Shapa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141681085","display_name":"U. Ferrari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U Ferrari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G Hapfelmeier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Hapfelmeier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025510014","display_name":"Brigitta Bondy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Bondy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C Parsons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Parsons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066861106","display_name":"Kate E. Gilling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Gilling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084884200","display_name":"F Holsboer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Holsboer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3593406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.3813000023365021,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.3813000023365021,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.30320000648498535,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.24560000002384186,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9869999885559082},{"id":"https://openalex.org/keywords/5-ht3-receptor","display_name":"5-HT3 receptor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/serotonin-receptor-antagonism","display_name":"serotonin receptor antagonism","score":0.7149999737739563},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9520000219345093},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":0.9079999923706055},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/trimipramine","display_name":"trimipramine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/reboxetine","display_name":"reboxetine","score":0.9179999828338623},{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.7720000147819519},{"id":"https://openalex.org/keywords/sodium-current","display_name":"sodium current","score":0.550000011920929},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C2780250439","wikidata":"https://www.wikidata.org/wiki/Q423288","display_name":"Desipramine","level":4,"score":0.7455999851226807},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7264999747276306},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.6743000149726868},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.6424999833106995},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.63919997215271},{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.6355999708175659},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5985999703407288},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.5720999836921692},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.559499979019165},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5187000036239624},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.486299991607666},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4731000065803528},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.46869999170303345},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.45410001277923584},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.4496999979019165},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.4392000138759613},{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.4171000123023987},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.4101000130176544},{"id":"https://openalex.org/C156927020","wikidata":"https://www.wikidata.org/wiki/Q1187783","display_name":"Neurotransmitter receptor","level":3,"score":0.4065000116825104},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.3903999924659729},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.37389999628067017},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32839998602867126},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3208000063896179},{"id":"https://openalex.org/C2993285035","wikidata":"https://www.wikidata.org/wiki/Q2643251","display_name":"Synaptic cleft","level":4,"score":0.31709998846054077},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31450000405311584},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.3140000104904175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.310699999332428},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.3043000102043152},{"id":"https://openalex.org/C2779657639","wikidata":"https://www.wikidata.org/wiki/Q908843","display_name":"Tricyclic antidepressant","level":4,"score":0.298799991607666},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.2542000114917755}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.571.8592","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.571.8592","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.chrisparsons.de/Chris/Acrobat/Eisensamer_2003.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2107202738","https://openalex.org/W2055122000","https://openalex.org/W4256026974","https://openalex.org/W2120508643","https://openalex.org/W2091737392","https://openalex.org/W2113425599","https://openalex.org/W4230213340","https://openalex.org/W2031144740","https://openalex.org/W7140250120","https://openalex.org/W2079526280"],"abstract_inverted_index":{"Antidepressants":[0],"are":[1],"commonly":[2],"supposed":[3],"to":[4,17],"enhance":[5],"serotonergic":[6,95],"and/or":[7],"noradrenergic":[8,92],"neurotransmission":[9],"by":[10],"inhibition":[11,24],"of":[12,25,35,43,65,117,143,159],"neurotransmitter":[13,20],"reuptake":[14,82,87],"through":[15,23],"binding":[16],"the":[18,26,30,50,80,85,91,100,115,136,156],"respective":[19],"transporters":[21],"or":[22],"monoamine":[27],"oxidase.":[28],"Using":[29],"concentration-clamp":[31],"technique":[32],"and":[33,60,69,78,90,93,103,123,130,145],"measurements":[34],"intracellular":[36],"Ca2\u00fe,":[37],"we":[38,147],"demonstrate":[39],"that":[40,149],"different":[41],"classes":[42],"antidepressants":[44,75],"act":[45],"as":[46],"functional":[47],"antagonists":[48],"at":[49,61],"human":[51],"5-HT3A":[52],"receptor":[53,127],"stably":[54],"expressed":[55],"in":[56,105],"HEK":[57],"293":[58],"cells":[59],"endogenous":[62],"5-HT3":[63],"receptors":[64],"rat":[66],"hippocampal":[67],"neurons":[68],"N1E-115":[70],"neuroblastoma":[71],"cells.":[72],"The":[73],"tricyclic":[74,160],"desipramine,":[76],"imipramine,":[77,121],"trimipramine,":[79,122],"serotonin":[81],"inhibitor":[83,88],"fluoxetine,":[84],"norepinephrine":[86],"reboxetine,":[89],"specific":[94],"antidepressant":[96],"mirtazapine":[97],"effectively":[98],"reduced":[99],"serotonin-induced":[101,137],"Na\u00fe-":[102],"Ca2\u00fe-currents":[104],"a":[106,150],"dose-dependent":[107],"fashion.":[108],"This":[109],"effect":[110,134],"was":[111],"voltage-independent":[112],"and,":[113],"with":[114],"exception":[116],"mirtazapine,":[118],"noncompetitive.":[119],"Desipramine,":[120],"fluoxetine":[124],"also":[125],"accelerated":[126],"desensitization.":[128],"Moclobemide":[129],"carbamazepine":[131],"had":[132],"no":[133],"on":[135],"cation":[138],"current.":[139],"By":[140],"analyzing":[141],"analogues":[142],"desipramine":[144],"carbamazepine,":[146],"found":[148],"basic":[151],"propylamine":[152],"side":[153],"chain":[154],"increases":[155],"antagonistic":[157],"potency":[158]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-27T00:00:00"}